FDA Pediatric back panel doses for kids' Tylenol

SILVER SPRING, Maryland - federal health experts said Wednesday that dosing instructions for children under the age of 2 years old should be added to children Tylenol and similar products containing acetaminophen, reducing fever and popular pain reliever.

A panel of advisers to the Food and Drug Administration voted 21-0 for adding doses for children from 6 months to 2 years to over-the-counter acetaminophen formulas. The FDA convened a meeting of two days to take into account the changes that will make it safer and easier to use formulas.

Liquid formulas have never contained dosage information for children of less than 2 to avoid an overdose and to encourage parents to get medical care for sick children. Fever in children aged 6 months may be associated with dangerous infections such as meningitis and pneumonia.

Members of the panel of the FDA, said the lack of information contributes to the confusion and can lead to dose incorrectly children, parents. Acetaminophen overdose are more common in children under the age of 2 and have increased over the past ten years, according to data from the FDA.

Acetaminophen is especially widely used in the United States, sold drugs in hundreds of formulations and associations with other ingredients. Meeting on Wednesday with a small group of products single ingredient, including J & J child and baby Tylenol, Novartis Triaminic, little fevers of Prestige brands and various brands of Pharmacy

While safe when used as directed, acetaminophen has long been submitted to warning labels, because it can cause damage to the liver when the overallocation. Determination of errors with the products of acetaminophen children represented 2.8 per cent, or 7 500, emergency 270,165 indicated in poison control last year, according to the American Association of Poison Control centres centres.

Overdoses can be caused by parents unable to read the label, misinterpreting the dosage instructions or with a spoon or other container instead of the Cup included with the product.

Support for the FDA panelists and the efforts of the manufacturer to improve the labelling of products, but some noted that the proposed amendments have been discussed at the meetings of the FDA since the mid-1990s.

"There are 16 years later, and we still do not have a clear and effective label for this product, said Amy Celento, representative of the group." "" It takes much too long - we do not follow the example of offshore drilling and wait for a disaster before make us the necessary changes. ?

FDA is not required to follow the recommendations of its advisory panels, although it often does. The FDA will use the discussion of this week to write restrictive guidelines for cash.

In a separate vote Wednesday, the Committee voted unanimously that drugs should include dosage information based on the weight of the children, which is considered far more precise dosage. Almost all prescription drugs manufacturers already include a determination table with the weight and age. But the panelists said instructions should emphasize that the weight is the preferred approach.

Among the other changes recommended by the Committee, the limiting measures Cup millilitres. Several sections now contain trademarks spoonful tea / milliliter, said panelists may cause confusion.

The Consumer Healthcare Products Association said in a statement after the Panel that he supported the recommendations of "give parents and caregivers dosage information more accurate and detailed where it is necessary - directly on the drug facts label here.

A day earlier the Group introduced voluntary measures it has taken to take medication for children safer and easier to use. Member companies include J & J, Novartis, GlaxoSmithKline PLC and drug manufacturers generic acetaminophen as Perrigo Co.

Earlier this month, the Group announced that it will voluntarily eliminate infant acetaminophen drugs drops. For decades, industry marketed high dose of infant formula, usually delivered with a pipette, so that parents could give babies a more small amount of liquid. But from this year manufacturers later will switch all infant formulas in the same dosage used in child acetaminophen products.

In its final vote, the Group recommended 17-3, with 1 abstention, the FDA to consider mandating a single dose of acetaminophen solid for children.

Chronic use of Tylenol may be linked to cancer of the blood, the study suggests

those who take acetaminophen - best known as Tylenol - regularly for some time could bring themselves to an increased risk of developing certain cancers of the blood, researchers from the University of Washington report.

The results of previous studies looking at the association between over-the-counter analgesics or nonsteroidal anti-inflammatory drugs (NSAIDs) and cancers of the blood were mixed, but this study suggests a risk associated with acetaminophen, scientists noted.

"We found that the heavy use of acetaminophen, one of the most frequently used drugs in the world, was associated with a malignant hematological incidents increased nearly double risk," said lead researcher Dr. Roland Walter, an assistant professor of medicine in the division of Hematology.

The report was published in the online edition may 9 of the Journal of Clinical Oncology.

While research has revealed a possible association between acetaminophen use cancers and blood, he has failed to prove a cause and effect. And several experts called for follow-up studies.

The study, Walter team collected data on men and women aged 50 to 76, 64,839 who participated in the vitamins and to study the habits of life (VITAL). Among these people, the researchers identified 577 cases of cancer of the blood.

The researchers found that those who used acetaminophen at least four days a week for four years had almost a double risk increased for cancers of the blood. These cancers included: myeloid neoplasms, non-Hodgkin's lymphoma and plasma cell disorders.

However, acetaminophen use was not associated with an increased risk to the chronic lymphocytic leukemia/small Lymphocytic Lymphoma, Walter Group noted.

This risk was not seen with the mass use of other pain relievers such as aspirin, other NSAIDs or ibuprofen, researchers said. However, it there was also no association between other analgesics and risk reduction, which implies that these drugs are likely to be useful for the prevention of cancers of the blood, said Walter.

"Acetaminophen used on most of the day for many years seems to be associated with this new adverse effect," said Walter. "However, the study does not find a causal link," he added.

According to researchers, animal studies have linked acetaminophen to the toxic effects on the bone marrow, what could be the reason for which there is a higher risk for cancers of the blood with a long-term drug use.

Bonnie Jacobs, a spokesman for McNeil Consumer Healthcare, a division of McNeil-PPC, Inc., maker of Tylenol, stressed that "Tylenol has a clinical record in support of the safety and efficacy of more than 50 years".

She added, "We appreciate the evaluation of the authors that more studies are needed before, it is possible to draw conclusions about the use of acetaminophen, and we welcome additional research in this area."

Walter noted that the risk of cancers of the blood is relatively low. a total combined estimated of 137,260 the United States people were diagnosed with leukemia, lymphoma or myeloma in 2010. "New cases of leukemia, lymphoma and myeloma should represent 9 per cent of new cases of cancer diagnosed, so even a doubling of that risk is still relatively low,", he said.

Deborah banker, Senior Vice President, communications research at the Leukemia & Lymphoma Society, stated that "it is unknown why chronic lymphocytic leukemia/small Lymphocytic Lymphoma should be associations of different risk with use of acetaminophen.".

Eric Jacobs, strategic Director of Pharmacoepidemiology at the American Cancer Society, said that "there is no evidence of this study that the less frequent use or more short term may raise risk of these cancers." Replication of this finding in additional studies of quality is necessary. ?

Chronic use of Tylenol may be linked to cancer of the blood, the study suggests

those who take acetaminophen - best known as Tylenol - regularly for some time could bring themselves to an increased risk of developing certain cancers of the blood, researchers from the University of Washington report.

The results of previous studies looking at the association between over-the-counter analgesics or nonsteroidal anti-inflammatory drugs (NSAIDs) and cancers of the blood were mixed, but this study suggests a risk associated with acetaminophen, scientists noted.

"We found that the heavy use of acetaminophen, one of the most frequently used drugs in the world, was associated with a malignant hematological incidents increased nearly double risk," said lead researcher Dr. Roland Walter, an assistant professor of medicine in the division of Hematology.

The report was published in the online edition may 9 of the Journal of Clinical Oncology.

While research has revealed a possible association between acetaminophen use cancers and blood, he has failed to prove a cause and effect. And several experts called for follow-up studies.

The study, Walter team collected data on men and women aged 50 to 76, 64,839 who participated in the vitamins and to study the habits of life (VITAL). Among these people, the researchers identified 577 cases of cancer of the blood.

The researchers found that those who used acetaminophen at least four days a week for four years had almost a double risk increased for cancers of the blood. These cancers included: myeloid neoplasms, non-Hodgkin's lymphoma and plasma cell disorders.

However, acetaminophen use was not associated with an increased risk to the chronic lymphocytic leukemia/small Lymphocytic Lymphoma, Walter Group noted.

This risk was not seen with the mass use of other pain relievers such as aspirin, other NSAIDs or ibuprofen, researchers said. However, it there was also no association between other analgesics and risk reduction, which implies that these drugs are likely to be useful for the prevention of cancers of the blood, said Walter.

"Acetaminophen used on most of the day for many years seems to be associated with this new adverse effect," said Walter. "However, the study does not find a causal link," he added.

According to researchers, animal studies have linked acetaminophen to the toxic effects on the bone marrow, what could be the reason for which there is a higher risk for cancers of the blood with a long-term drug use.

Bonnie Jacobs, a spokesman for McNeil Consumer Healthcare, a division of McNeil-PPC, Inc., maker of Tylenol, stressed that "Tylenol has a clinical record in support of the safety and efficacy of more than 50 years".

She added, "We appreciate the evaluation of the authors that more studies are needed before, it is possible to draw conclusions about the use of acetaminophen, and we welcome additional research in this area."

Walter noted that the risk of cancers of the blood is relatively low. a total combined estimated of 137,260 the United States people were diagnosed with leukemia, lymphoma or myeloma in 2010. "New cases of leukemia, lymphoma and myeloma should represent 9 per cent of new cases of cancer diagnosed, so even a doubling of that risk is still relatively low,", he said.

Deborah banker, Senior Vice President, communications research at the Leukemia & Lymphoma Society, stated that "it is unknown why chronic lymphocytic leukemia/small Lymphocytic Lymphoma should be associations of different risk with use of acetaminophen.".

Eric Jacobs, strategic Director of Pharmacoepidemiology at the American Cancer Society, said that "there is no evidence of this study that the less frequent use or more short term may raise risk of these cancers." Replication of this finding in additional studies of quality is necessary. ?